Chemotherapy induced neurotoxicity in cancer survivors assessed through a dual database bibliometric analysis from 2005 to 2025
This study presents the first dual-database bibliometric landscape of CIPN and CRCI, offering valuable insights into their pathophysiological underpinnings and intervention development. By framing these neurotoxicities as critical survivorship issues, the findings emphasize the urgent need for comprehensive, mechanism-driven, and survivor-centered management strategies to enhance long-term quality of life in cancer survivors.
Authors
- Boxiang Zhang (ORCID: https://orcid.org/0000-0002-5010-0275)
- Zhimin Wu (ORCID: https://orcid.org/0000-0002-7374-6693)
- Yi Chen (ORCID: https://orcid.org/0009-0002-7413-2463)
- Lucy Yue Lau
Institutions
- Massachusetts Department of Public Health (US)
- Harvard University (US)
- Guiyang Medical University (CN)
- Xinjiang Medical University (CN)
- Tumor Hospital of Xinjiang Medical University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- Xinjiang University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1007/s12672-025-03802-7
- Citations
- 4
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 6.07